Myomo, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Myomo, Inc. (MYO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $197.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-05
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $7.49M.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $0.00.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $508.19K.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-06-30 was $0.00.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $7.49M, a 1374.30% increase from fiscal 2023.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $508.19K, a 125.19% increase from fiscal 2022.
- Myomo, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $225.66K, a 65.50% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $197.37K 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $7.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $7.49M 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $508.19K derived: sum of 2 quarters · filed 2025-03-10 | $508.19K derived: sum of 3 quarters · filed 2025-03-10 | $508.19K 10-K · filed 2025-03-10 |
| 2023-09-30 | $508.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $508.19K derived: sum of 2 quarters · filed 2024-11-06 | $508.19K 10-Q · filed 2024-11-06 | $508.19K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $0.00 derived: sum of 3 quarters · filed 2024-03-08 | $225.66K 10-K · filed 2024-03-08 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $225.66K 10-Q · filed 2023-11-07 | $225.66K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $225.66K 10-Q · filed 2023-08-09 | $225.66K derived: sum of 3 quarters · filed 2023-08-09 | $225.66K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $225.66K 10-Q · filed 2023-05-10 | $225.66K derived: sum of 2 quarters · filed 2023-05-10 | $225.66K derived: sum of 3 quarters · filed 2023-05-10 | $225.66K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $0.00 derived: sum of 2 quarters · filed 2023-03-13 | $0.00 derived: sum of 3 quarters · filed 2023-03-13 | $654.09K 10-K · filed 2023-03-13 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $654.09K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $654.09K 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $654.09K 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $172.07K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |